Using sodium molybdate to treat chronic copper toxicity in dairy cows: A practical approach.

New Zealand veterinary journal (2013-11-13)
Pl Morgan, Nd Grace, Dp Lilley
RESUMO

Abstract A Jersey herd of 350 cows and 70 heifers located in the Taranaki region of New Zealand ceased milking in June 2011. Ten cows died during the subsequent 14 days. For at least 9 months, the cows had received palm kernel expeller (PKE) and molasses supplements. Additional Cu supplementation was provided through the water system. Total Cu intake was calculated to be 400 mg/day/cow. Half of the cows died suddenly while others presented with anorexia, depression and ataxia, which progressed to recumbency and death after 1 to 3 days. Clinical signs were mild dehydration, cyanosis and firm faeces which were covered in dark blood. Mean concentrations of Cu in liver and kidney in three of the dead cows were 3,900 and 440 µmol/kg fresh weight (FW), respectively. Haemorrhages were observed throughout the alimentary tracts and in muscles, and there were ecchymotic haemorrhages on the epi- and endocardia. The livers were swollen and the gall bladder walls were inflamed. High concentrations of Cu in the liver and kidney are characteristic findings of chronic Cu toxicity. The remaining herd was fed 200 mg Mo, as sodium molybdate, per cow per day and all Cu supplements were removed including those provided by the water supply. This reduced mean concentrations of Cu in liver from 3,100 to 1,320 µmol/kg FW within 26 days in the five live animals that were biopsied. There were no further deaths. In dairy herds where excessive Cu intakes have resulted in high liver Cu concentrations and caused chronic Cu toxicity, the removal of all Cu supplements and provision of high intakes of Mo (200 mg/cow/day) can markedly reduce liver Cu stores within 4 weeks.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Sodium molybdate dihydrate, ACS reagent, ≥99%
Sigma-Aldrich
Sodium molybdate dihydrate, ≥99.5%
Sigma-Aldrich
Sodium molybdate, ≥98%
Sigma-Aldrich
Sodium molybdate dihydrate, ≥99.5%, suitable for plant cell culture
Sigma-Aldrich
Molybdenum, powder, <150 μm, 99.9% trace metals basis
Sigma-Aldrich
Molybdenum, foil, thickness 0.1 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Sodium molybdate, anhydrous, powder, −100 mesh particle size, 99.9% trace metals basis
Sigma-Aldrich
Molybdenum, powder, <150 μm, 99.99% trace metals basis
Sigma-Aldrich
Molybdenum, powder, 1-5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
Sodium molybdate dihydrate, 99.99% trace metals basis
Sigma-Aldrich
Molybdenum, wire, diam. 1.0 mm, 99.95% trace metals basis
Sigma-Aldrich
Molybdenum, foil, thickness 1.0 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Molybdenum, foil, thickness 0.025 mm, ≥99.9% trace metals basis
Molybdenum, wire reel, 100m, diameter 0.5mm, annealed, 99.95%
Molybdenum, foil, 6mm disks, thickness 0.5mm, annealed, 99.9%
Molybdenum, foil, 6mm disks, thickness 0.75mm, annealed, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.005mm, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.006mm, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.007mm, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.008mm, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.009mm, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.0125mm, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.015mm, annealed, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.015mm, as rolled, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.01mm, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.01mm, annealed, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.020mm, annealed, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.025mm, annealed, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.03mm, annealed, 99.9%
Molybdenum, foil, 8mm disks, thickness 0.05mm, annealed, 99.9%

Redes sociais

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Pesquisa. Desenvolvimento. Produção.

Somos um fornecedor global líder para o setor de ciências biológicas, com soluções e serviços para pesquisa, desenvolvimento e produção de biotecnologia, além de produção e desenvolvimento de terapias farmacológicas com medicamentos.

© 2021 Merck KGaA, Darmstadt, Alemanha e/ou suas filiais. Todos os direitos reservados.

A reprodução não autorizada de quaisquer materiais deste site é estritamente proibida.